Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells

Shennan, D.B. and Thomson, Jean (2008) Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells. Oncology Reports, 20 (4). pp. 885-889. ISSN 1021-335X

Full text not available in this repository.Request a copy from the Strathclyde author

Abstract

It has been suggested that system L (LAT1/CD98hc) is up-regulated in cancer cells, including breast tumour cells, and is therefore a promising molecular target to inhibit or limit tumour cell growth. In view of this, we have examined the effect of BCH and other inhibitors of system L on the growth of MCF-7, ZR-75-1 and MDA-MB-231 cells. Treating cells with BCH markedly inhibited the metabolism of WST-1 in a dose-dependent fashion. Similarly, melphalan and D-leucine inhibited the growth of cultured breast cancer cells whereas MeAIB, an inhibitor of system A, was without effect. The effects of BCH and melphalan on cell growth were non-additive suggesting that both compounds were acting at a single locus. The results indicate that system L is required to maintain MCF-7, ZR-75-1 and MDA-MB-231 cell growth and support the notion that LAT1/CD98hc may be a suitable target to inhibit breast cancer progression.

Creators(s): Shennan, D.B. and Thomson, Jean;
Item type:Article
ID code:19484
Keywords:breast cancer, amino acid uptake, LAT1, Neoplasms. Tumors. Oncology (including Cancer), Pharmacy and materia medica, Cancer Research, Oncology
Subjects:Medicine > Internal medicine > Neoplasms. Tumors. Oncology (including Cancer)
Medicine > Pharmacy and materia medica
Department:Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Depositing user: Strathprints Administrator
Date deposited:08 Jun 2010 13:41
Last modified:12 Feb 2021 04:33
URI:https://strathprints.strath.ac.uk/id/eprint/19484
Export data:
CORE (COnnecting REpositories)